Focal cortical dysplasia （FCD） is one of the common pathological types of focal epilepsy in clinical practice， and most of FCD patients show drug resistance immediately after the onset of epilepsy and become intractable epilepsy. The new pathological classification of FCD proposed by the International League against Epilepsy in 2011 helps us gain a better understanding of FCD. With the development of medical detection technology， pathological research， and neuroimaging technology in recent years， the research on different pathological subtypes has helped clinicians to have a new understanding of the pathogenesis of FCD and the decision of treatment measures. With reference to related articles in recent years， this article reviews the clinical features， treatment methods， and prognosis of different subtypes of FCD， in order to provide help for clinical decision-making.